Drugs five years later: clonidine.

Area of Science:

• Pharmacology
• Cardiovascular Medicine

Background:

• Clonidine is a novel antihypertensive agent acting as a partial alpha-adrenergic antagonist.
• Its mechanism involves reducing cardiac output while maintaining peripheral vascular resistance at rest.

Purpose of the Study:

• To evaluate the hemodynamic effects of clonidine.
• To assess the impact of clonidine on blood pressure regulation during orthostasis and exercise.
• To investigate the phenomenon of rebound hypertension following abrupt clonidine withdrawal.

Main Methods:

• Hemodynamic assessment of blood pressure reduction.
• Evaluation of reflex control mechanisms during postural changes and physical activity.
• Monitoring for adverse events, particularly rebound hypertension.

Main Results:

• Clonidine reduces blood pressure by decreasing cardiac output; peripheral resistance remains stable at rest.
• Orthostatic and exercise blood pressure regulation is generally preserved, with infrequent orthostatic hypotension.
• Concomitant diuretic use enhances clonidine's antihypertensive efficacy in mild hypertension.

Conclusions:

• Clonidine is effective for mild hypertension, often requiring combination therapy with diuretics.
• While generally well-tolerated, abrupt cessation carries a risk of rebound hypertension and sympathetic overactivity.
• Further research is needed to fully understand rebound hypertension incidence and blood pressure responses during physical activity.